PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
20-May-2025 Global Anti-Adhesion Barrier Gels Market Set to Surge to USD 209.8 Million by 2032, Driven by Rising Surgical Procedures and Technological Advancements | FMI MARKITWIRED
19-May-2025 Zomedica Unveils Exclusive Fourth Friday at Four Webinar Series to Explore Cutting-Edge Veterinary Innovations ACCESS Newswire
19-May-2025 AGFA HealthCare Recognized for Proactive Partnerships and Communication in 2025 in the KLAS PACS Market Report - Earning a Top Performer Position for PACS Performance Across All Site Sizes ACCESS Newswire
19-May-2025 BULLETIN from Annual General Meeting in Senzime AB (publ) ACCESS Newswire
19-May-2025 Repair Biotechnologies Receives Orphan Drug Designation From the FDA for the Treatment of Homozygous Familial Hypercholesterolemia ACCESS Newswire
19-May-2025 Emergency Care Partners Establishes a New Partner Group in Illinois ACCESS Newswire
19-May-2025 Sinceri Senior Living Earns Great Place to Work Certification for 7th Consecutive Year ACCESS Newswire
19-May-2025 CrossTx Inc. Selected by EverCare Mobile Health to Power Care Management Platform for Long-Term Mental Health Innovation Across Idaho ACCESS Newswire
19-May-2025 CLS Health and Houston Food Bank Unite to Fight Hunger in Houston ACCESS Newswire
19-May-2025 Interactive Strength Inc. (Nasdaq: TRNR) Updates FAQ's about Increasing 2025 Pro Forma Revenue Guidance to More Than $75M and Other Questions ACCESS Newswire
19-May-2025 CASI Pharmaceuticals Provides Business and Clinical Update ACCESS Newswire
19-May-2025 enVVeno Medical Appoints Jennifer Bright as Chief Financial Officer ACCESS Newswire
19-May-2025 Onvida Health and Ambience Healthcare Partner to Enhance Patient Care and Revolutionize Clinical Workflows with AI Technology ACCESS Newswire
19-May-2025 Tharimmune Appoints Renowned Counter-Terrorism and Critical Infrastructure Expert James Gordon Liddy (CDR US Navy SEAL (Ret)) as Key Strategic Advisor Against Weaponized Fentanyl and Other High-Potency Opioids Following Positive FDA Feedback ACCESS Newswire
19-May-2025 Interactive Strength Inc. (Nasdaq: TRNR) Reports First Quarter 2025 Results, Increases 2025 Pro Forma Revenue Guidance to more than $75M ACCESS Newswire
19-May-2025 Gat Sport Partners With 24 Hour Fitness to Launch Nitraflex Ultra ACCESS Newswire
19-May-2025 Ainos Reports Breakthrough Interim Results in VELDONA Clinical Trial for FCGS, Signaling New Era in Companion Animal Immunotherapy ACCESS Newswire
19-May-2025 BODYWELE Offers Expanded Emsculpt NEO Treatments Following FDA Clearance for Functional Wellness Use ACCESS Newswire
19-May-2025 Aspira Announces First Quarter 2025 Financial Results and Provides Business Update ACCESS Newswire
19-May-2025 Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders ACCESS Newswire